EUVIMEDEUVIMED entdecken
Crossref

Centromedian region thalamic responsive neurostimulation mitigates idiopathic generalized and multifocal epilepsy with focal to bilateral tonic–clonic seizures

Pranav Nanda iD, Nathaniel Sisterson, Ashley Walton, Catherine J Chu iD, Sydney S Cash, Lidia M V R Moura iD, Joel M Oster iD, Alexandra Urban, Robert Mark Richardson iD

Epilepsia · 2024

DOI: 10.1111/epi.18070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2024. Verfasst von Pranav Nanda und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Epilepsy, Generalized, Drug Resistant Epilepsy. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Although >30% of epilepsy patients have drug‐resistant epilepsy (DRE), typically those with generalized or multifocal disease have not traditionally been considered surgical candidates. Responsive neurostimulation (RNS) of the centromedian (CM) region of the thalamus now appears to be a promising therapeutic option for this patient population. We present outcomes following CM RNS for 13 patients with idiopathic generalized epilepsy (IGE) and eight with multifocal onsets that rapidly generalize to bilateral tonic–clonic (focal to bilateral tonic–clonic [FBTC]) seizures.

Methods

A retrospective review of all patients undergoing bilateral CM RNS by the senior author through July 2022 were reviewed. Electrodes were localized and volumes of tissue activation were modeled in Lead‐DBS. Changes in patient seizure frequency were extracted from electronic medical records.

Results

Twenty‐one patients with DRE underwent bilateral CM RNS implantation. For 17 patients with at least 1 year of postimplantation follow‐up, average seizure reduction from preoperative baseline was 82.6% (SD = 19.0%, median = 91.7%), with 18% of patients Engel class 1, 29% Engel class 2, 53% Engel class 3, and 0% Engel class 4. There was a trend for average seizure reduction to be greater for patients with nonlesional FBTC seizures than for other patients. For patients achieving at least Engel class 3 outcome, median time to worthwhile seizure reduction was 203.5 days (interquartile range = 110.5–343.75 days). Patients with IGE with myoclonic seizures had a significantly shorter time to worthwhile seizure reduction than other patients. The surgical targeting strategy evolved after the first four subjects to achieve greater anatomic accuracy. Significance Patients with both primary and rapidly generalized epilepsy who underwent CM RNS experienced substantial seizure relief. Subsets of these patient populations may particularly benefit from CM RNS. The refinement of lead targeting, tuning of RNS system parameters, and patient selection are ongoing areas of investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epilepsy, GeneralizedDrug Resistant EpilepsyHumansFemaleMaleAdultRetrospective StudiesYoung AdultAdolescentTreatment OutcomeMiddle AgedIntralaminar Thalamic NucleiSeizuresDeep Brain StimulationEpilepsy, Tonic-ClonicEpilepsies, PartialChild

Stichwörter der Autor:innen

RNS therapygeneralized epilepsyneuromodulationsurgerythalamus

Autor:innen und Institutionen

  • Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Neurosurgery, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Neurology, Tufts Medical Center, Boston, Massachusetts, USA.
  • Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Pranav Nanda, Catherine J Chu, Lidia M V R Moura, Joel M Oster, Robert Mark Richardson

Zitieren

APA

Nanda, P., Sisterson, N., Walton, A., Chu, C. J., Cash, S. S., Moura, L. M. V. R., Oster, J. M., Urban, A., & Richardson, R. M. (2024). Centromedian region thalamic responsive neurostimulation mitigates idiopathic generalized and multifocal epilepsy with focal to bilateral tonic–clonic seizures. Epilepsia. https://doi.org/10.1111/epi.18070

Vancouver

Nanda P, Sisterson N, Walton A, Chu CJ, Cash SS, Moura LMVR, et al. Centromedian region thalamic responsive neurostimulation mitigates idiopathic generalized and multifocal epilepsy with focal to bilateral tonic–clonic seizures. Epilepsia. 2024. doi:10.1111/epi.18070

BibTeX
@article{Nanda2024,
  author = {Nanda, Pranav and Sisterson, Nathaniel and Walton, Ashley and Chu, Catherine J and Cash, Sydney S and Moura, Lidia M V R and Oster, Joel M and Urban, Alexandra and Richardson, Robert Mark},
  title = {Centromedian region thalamic responsive neurostimulation mitigates idiopathic generalized and multifocal epilepsy with focal to bilateral tonic–clonic seizures},
  journal = {Epilepsia},
  year = {2024},
  doi = {10.1111/epi.18070}
}
Kostenlos starten →